Skip to main content

Deep Vein Thrombosis clinical trials at UC Davis
2 research studies open to eligible people

  • A Registry Study: Global Anticoagulant Registry for Venous Thromboembolic Events (blood clot in a vein)

    “We invite you to take part in a research study because you have recently been diagnosed with a blood clot in your leg or chest.”

    open to eligible people ages 18-99

    The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: - treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) - Rate of early and late symptomatic VTE recurrence - Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension - Rate of bleeding complications - Rate of all-cause mortality at six months

    Muscle Shoals, Alabama

  • A Study of the Duration of Therapy for Thrombosis (blood clot inside a blood vessel) in Children

    “This study will help us learn more about the best type of treatment for children with blood clots in their veins (thrombosis).”

    open to eligible people ages up to 20 years

    The Kids-DOTT trial is a randomized controlled clinical trial whose primary objective is to evaluate non-inferiority of shortened-duration (6 weeks) versus conventional-duration (3 months) anticoagulation in children with first-episode acute venous thrombosis. The first stage of the trial has consisted of a pilot/feasibility component, which then continues as the definitively-powered trial.

    Sacramento, California and other locations

Last updated: